Acute Myocardial Infarction and Cardiogenic Shock Interventional Approach to Management in the Cardiac Catheterization Laboratories

Despite advances in early reperfusion and a technologic renaissance in the space of Mechanical Circulatory Support (MCS), Cardiogenic Shock (CS) remains the leading cause of in-hospital mortality following Acute Myocardial Infarction (AMI). Given the challenges inherent to conducting adequately powe...

Full description

Saved in:
Bibliographic Details
Published in:Current cardiology reviews 2022-03, Vol.18 (2), p.e251121198293-e251121198293
Main Authors: Tehrani, Behnam N, Damluji, Abdulla A, Batchelor, Wayne B
Format: Article
Language:English
Subjects:
Aged
Best practice
Cardiac catheterization
Cardiac Catheterization - adverse effects
Catheterization
Clinical trials
Heart
Heart attacks
Hemodynamics
Humans
Intubation
Laboratories
Myocardial infarction
Myocardial Infarction - complications
Myocardial Infarction - therapy
Patients
Reperfusion
Shock
Shock, Cardiogenic - diagnosis
Shock, Cardiogenic - etiology
Shock, Cardiogenic - therapy
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c451t-c5742acf9fca56814575ea776a04af03ecdb07a54515c3d00f2c23513a4ce47d3
cites cdi_FETCH-LOGICAL-c451t-c5742acf9fca56814575ea776a04af03ecdb07a54515c3d00f2c23513a4ce47d3
container_end_page e251121198293
container_issue 2
container_start_page e251121198293
container_title Current cardiology reviews
container_volume 18
creator Tehrani, Behnam N
Damluji, Abdulla A
Batchelor, Wayne B
description Despite advances in early reperfusion and a technologic renaissance in the space of Mechanical Circulatory Support (MCS), Cardiogenic Shock (CS) remains the leading cause of in-hospital mortality following Acute Myocardial Infarction (AMI). Given the challenges inherent to conducting adequately powered randomized controlled trials in this time-sensitive, hemodynamically complex, and highly lethal syndrome, treatment recommendations have been derived from AMI patients without shock. In this review, we aimed to (1) examine the pathophysiology and the new classification system for CS; (2) provide a comprehensive, evidence-based review for best practices for interventional management of AMI-CS in the cardiac catheterization laboratory; and (3) highlight the concept of how frailty and geriatric syndromes can be integrated into the decision process and where medical futility lies in the spectrum of AMI-CS care. Management strategies in the cardiac catheterization laboratory for CS include optimal vascular access, periprocedural antithrombotic therapy, culprit lesion versus multi-vessel revascularization, selective utilization of hemodynamic MCS tailored to individual shock hemometabolic profiles, and management of cardiac arrest. Efforts to advance clinical evidence for patients with CS should be concentrated on (1) the coordination of multi-center registries; (2) development of pragmatic clinical trials designed to evaluate innovative therapies; (3) establishment of multidisciplinary care models that will inform quality care and improve clinical outcomes.
doi_str_mv 10.2174/1573403X17666211125090929
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9413732</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2643080737</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-c5742acf9fca56814575ea776a04af03ecdb07a54515c3d00f2c23513a4ce47d3</originalsourceid><addsrcrecordid>eNp1kU2LFDEQhoMo7jr6FyTixUtrvjN9EYbBj4VZPKjgLdRUp2ey9iRj0r2wXv3jpp11UcFTJVXP-1LJS8gzzl4KbtUrrq1UTH7h1hgjOOdCs5a1or1HzvnS6sZobe_Xc-WaGTwjj0q5YkwL0_KH5EyqpZDK8HPyY4XT6OnlTULIXYCBXsQeMo4hRQqxo-u5nXY-BqQf9wm_VmD0-drHGan86njMCXBPx0QvIcLOH-qMhkjHvT_JAWutt6oL3-GX9Qa2KcOYcvDlMXnQw1D8k9u6IJ_fvvm0ft9sPry7WK82DSrNxwa1VQKwb3sEbZZcaas9WGuAKeiZ9NhtmQVdYY2yY6wXKKTmEhR6ZTu5IK9Pvsdpe_Ad1jUzDO6YwwHyjUsQ3N-TGPZul65dq7i0UlSDF7cGOX2bfBndIRT0wwDRp6k4YZhi3GjOKvr8H_QqTbn-10wpyZbMVssFaU8U5lRK9v3dMpy5OWr336ir9umfr7lT_s5W_gSVjadQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2643080737</pqid></control><display><type>article</type><title>Acute Myocardial Infarction and Cardiogenic Shock Interventional Approach to Management in the Cardiac Catheterization Laboratories</title><source>PubMed Central</source><creator>Tehrani, Behnam N ; Damluji, Abdulla A ; Batchelor, Wayne B</creator><creatorcontrib>Tehrani, Behnam N ; Damluji, Abdulla A ; Batchelor, Wayne B</creatorcontrib><description>Despite advances in early reperfusion and a technologic renaissance in the space of Mechanical Circulatory Support (MCS), Cardiogenic Shock (CS) remains the leading cause of in-hospital mortality following Acute Myocardial Infarction (AMI). Given the challenges inherent to conducting adequately powered randomized controlled trials in this time-sensitive, hemodynamically complex, and highly lethal syndrome, treatment recommendations have been derived from AMI patients without shock. In this review, we aimed to (1) examine the pathophysiology and the new classification system for CS; (2) provide a comprehensive, evidence-based review for best practices for interventional management of AMI-CS in the cardiac catheterization laboratory; and (3) highlight the concept of how frailty and geriatric syndromes can be integrated into the decision process and where medical futility lies in the spectrum of AMI-CS care. Management strategies in the cardiac catheterization laboratory for CS include optimal vascular access, periprocedural antithrombotic therapy, culprit lesion versus multi-vessel revascularization, selective utilization of hemodynamic MCS tailored to individual shock hemometabolic profiles, and management of cardiac arrest. Efforts to advance clinical evidence for patients with CS should be concentrated on (1) the coordination of multi-center registries; (2) development of pragmatic clinical trials designed to evaluate innovative therapies; (3) establishment of multidisciplinary care models that will inform quality care and improve clinical outcomes.</description><identifier>ISSN: 1573-403X</identifier><identifier>EISSN: 1875-6557</identifier><identifier>DOI: 10.2174/1573403X17666211125090929</identifier><identifier>PMID: 34823461</identifier><language>eng</language><publisher>United Arab Emirates: Benham Science Publishers</publisher><subject>Aged ; Best practice ; Cardiac catheterization ; Cardiac Catheterization - adverse effects ; Catheterization ; Clinical trials ; Heart ; Heart attacks ; Hemodynamics ; Humans ; Intubation ; Laboratories ; Myocardial infarction ; Myocardial Infarction - complications ; Myocardial Infarction - therapy ; Patients ; Reperfusion ; Shock ; Shock, Cardiogenic - diagnosis ; Shock, Cardiogenic - etiology ; Shock, Cardiogenic - therapy ; Treatment Outcome</subject><ispartof>Current cardiology reviews, 2022-03, Vol.18 (2), p.e251121198293-e251121198293</ispartof><rights>Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</rights><rights>Copyright Bentham Science Mar 2022</rights><rights>2022 Bentham Science Publishers 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-c5742acf9fca56814575ea776a04af03ecdb07a54515c3d00f2c23513a4ce47d3</citedby><cites>FETCH-LOGICAL-c451t-c5742acf9fca56814575ea776a04af03ecdb07a54515c3d00f2c23513a4ce47d3</cites><orcidid>0000-0002-8037-7021 ; 0000-0002-8774-6416 ; 0000-0002-3016-1150</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413732/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413732/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,733,786,790,891,27957,27958,53827,53829</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34823461$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tehrani, Behnam N</creatorcontrib><creatorcontrib>Damluji, Abdulla A</creatorcontrib><creatorcontrib>Batchelor, Wayne B</creatorcontrib><title>Acute Myocardial Infarction and Cardiogenic Shock Interventional Approach to Management in the Cardiac Catheterization Laboratories</title><title>Current cardiology reviews</title><addtitle>Curr Cardiol Rev</addtitle><description>Despite advances in early reperfusion and a technologic renaissance in the space of Mechanical Circulatory Support (MCS), Cardiogenic Shock (CS) remains the leading cause of in-hospital mortality following Acute Myocardial Infarction (AMI). Given the challenges inherent to conducting adequately powered randomized controlled trials in this time-sensitive, hemodynamically complex, and highly lethal syndrome, treatment recommendations have been derived from AMI patients without shock. In this review, we aimed to (1) examine the pathophysiology and the new classification system for CS; (2) provide a comprehensive, evidence-based review for best practices for interventional management of AMI-CS in the cardiac catheterization laboratory; and (3) highlight the concept of how frailty and geriatric syndromes can be integrated into the decision process and where medical futility lies in the spectrum of AMI-CS care. Management strategies in the cardiac catheterization laboratory for CS include optimal vascular access, periprocedural antithrombotic therapy, culprit lesion versus multi-vessel revascularization, selective utilization of hemodynamic MCS tailored to individual shock hemometabolic profiles, and management of cardiac arrest. Efforts to advance clinical evidence for patients with CS should be concentrated on (1) the coordination of multi-center registries; (2) development of pragmatic clinical trials designed to evaluate innovative therapies; (3) establishment of multidisciplinary care models that will inform quality care and improve clinical outcomes.</description><subject>Aged</subject><subject>Best practice</subject><subject>Cardiac catheterization</subject><subject>Cardiac Catheterization - adverse effects</subject><subject>Catheterization</subject><subject>Clinical trials</subject><subject>Heart</subject><subject>Heart attacks</subject><subject>Hemodynamics</subject><subject>Humans</subject><subject>Intubation</subject><subject>Laboratories</subject><subject>Myocardial infarction</subject><subject>Myocardial Infarction - complications</subject><subject>Myocardial Infarction - therapy</subject><subject>Patients</subject><subject>Reperfusion</subject><subject>Shock</subject><subject>Shock, Cardiogenic - diagnosis</subject><subject>Shock, Cardiogenic - etiology</subject><subject>Shock, Cardiogenic - therapy</subject><subject>Treatment Outcome</subject><issn>1573-403X</issn><issn>1875-6557</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp1kU2LFDEQhoMo7jr6FyTixUtrvjN9EYbBj4VZPKjgLdRUp2ey9iRj0r2wXv3jpp11UcFTJVXP-1LJS8gzzl4KbtUrrq1UTH7h1hgjOOdCs5a1or1HzvnS6sZobe_Xc-WaGTwjj0q5YkwL0_KH5EyqpZDK8HPyY4XT6OnlTULIXYCBXsQeMo4hRQqxo-u5nXY-BqQf9wm_VmD0-drHGan86njMCXBPx0QvIcLOH-qMhkjHvT_JAWutt6oL3-GX9Qa2KcOYcvDlMXnQw1D8k9u6IJ_fvvm0ft9sPry7WK82DSrNxwa1VQKwb3sEbZZcaas9WGuAKeiZ9NhtmQVdYY2yY6wXKKTmEhR6ZTu5IK9Pvsdpe_Ad1jUzDO6YwwHyjUsQ3N-TGPZul65dq7i0UlSDF7cGOX2bfBndIRT0wwDRp6k4YZhi3GjOKvr8H_QqTbn-10wpyZbMVssFaU8U5lRK9v3dMpy5OWr336ir9umfr7lT_s5W_gSVjadQ</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Tehrani, Behnam N</creator><creator>Damluji, Abdulla A</creator><creator>Batchelor, Wayne B</creator><general>Benham Science Publishers</general><general>Bentham Science Publishers</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8037-7021</orcidid><orcidid>https://orcid.org/0000-0002-8774-6416</orcidid><orcidid>https://orcid.org/0000-0002-3016-1150</orcidid></search><sort><creationdate>20220301</creationdate><title>Acute Myocardial Infarction and Cardiogenic Shock Interventional Approach to Management in the Cardiac Catheterization Laboratories</title><author>Tehrani, Behnam N ; Damluji, Abdulla A ; Batchelor, Wayne B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-c5742acf9fca56814575ea776a04af03ecdb07a54515c3d00f2c23513a4ce47d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Aged</topic><topic>Best practice</topic><topic>Cardiac catheterization</topic><topic>Cardiac Catheterization - adverse effects</topic><topic>Catheterization</topic><topic>Clinical trials</topic><topic>Heart</topic><topic>Heart attacks</topic><topic>Hemodynamics</topic><topic>Humans</topic><topic>Intubation</topic><topic>Laboratories</topic><topic>Myocardial infarction</topic><topic>Myocardial Infarction - complications</topic><topic>Myocardial Infarction - therapy</topic><topic>Patients</topic><topic>Reperfusion</topic><topic>Shock</topic><topic>Shock, Cardiogenic - diagnosis</topic><topic>Shock, Cardiogenic - etiology</topic><topic>Shock, Cardiogenic - therapy</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tehrani, Behnam N</creatorcontrib><creatorcontrib>Damluji, Abdulla A</creatorcontrib><creatorcontrib>Batchelor, Wayne B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Current cardiology reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tehrani, Behnam N</au><au>Damluji, Abdulla A</au><au>Batchelor, Wayne B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acute Myocardial Infarction and Cardiogenic Shock Interventional Approach to Management in the Cardiac Catheterization Laboratories</atitle><jtitle>Current cardiology reviews</jtitle><addtitle>Curr Cardiol Rev</addtitle><date>2022-03-01</date><risdate>2022</risdate><volume>18</volume><issue>2</issue><spage>e251121198293</spage><epage>e251121198293</epage><pages>e251121198293-e251121198293</pages><issn>1573-403X</issn><eissn>1875-6557</eissn><notes>ObjectType-Article-2</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-3</notes><notes>content type line 23</notes><notes>ObjectType-Review-1</notes><abstract>Despite advances in early reperfusion and a technologic renaissance in the space of Mechanical Circulatory Support (MCS), Cardiogenic Shock (CS) remains the leading cause of in-hospital mortality following Acute Myocardial Infarction (AMI). Given the challenges inherent to conducting adequately powered randomized controlled trials in this time-sensitive, hemodynamically complex, and highly lethal syndrome, treatment recommendations have been derived from AMI patients without shock. In this review, we aimed to (1) examine the pathophysiology and the new classification system for CS; (2) provide a comprehensive, evidence-based review for best practices for interventional management of AMI-CS in the cardiac catheterization laboratory; and (3) highlight the concept of how frailty and geriatric syndromes can be integrated into the decision process and where medical futility lies in the spectrum of AMI-CS care. Management strategies in the cardiac catheterization laboratory for CS include optimal vascular access, periprocedural antithrombotic therapy, culprit lesion versus multi-vessel revascularization, selective utilization of hemodynamic MCS tailored to individual shock hemometabolic profiles, and management of cardiac arrest. Efforts to advance clinical evidence for patients with CS should be concentrated on (1) the coordination of multi-center registries; (2) development of pragmatic clinical trials designed to evaluate innovative therapies; (3) establishment of multidisciplinary care models that will inform quality care and improve clinical outcomes.</abstract><cop>United Arab Emirates</cop><pub>Benham Science Publishers</pub><pmid>34823461</pmid><doi>10.2174/1573403X17666211125090929</doi><orcidid>https://orcid.org/0000-0002-8037-7021</orcidid><orcidid>https://orcid.org/0000-0002-8774-6416</orcidid><orcidid>https://orcid.org/0000-0002-3016-1150</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1573-403X
ispartof Current cardiology reviews, 2022-03, Vol.18 (2), p.e251121198293-e251121198293
issn 1573-403X
1875-6557
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9413732
source PubMed Central
subjects Aged
Best practice
Cardiac catheterization
Cardiac Catheterization - adverse effects
Catheterization
Clinical trials
Heart
Heart attacks
Hemodynamics
Humans
Intubation
Laboratories
Myocardial infarction
Myocardial Infarction - complications
Myocardial Infarction - therapy
Patients
Reperfusion
Shock
Shock, Cardiogenic - diagnosis
Shock, Cardiogenic - etiology
Shock, Cardiogenic - therapy
Treatment Outcome
title Acute Myocardial Infarction and Cardiogenic Shock Interventional Approach to Management in the Cardiac Catheterization Laboratories
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T03%3A17%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acute%20Myocardial%20Infarction%20and%20Cardiogenic%20Shock%20Interventional%20Approach%20to%20Management%20in%20the%20Cardiac%20Catheterization%20Laboratories&rft.jtitle=Current%20cardiology%20reviews&rft.au=Tehrani,%20Behnam%20N&rft.date=2022-03-01&rft.volume=18&rft.issue=2&rft.spage=e251121198293&rft.epage=e251121198293&rft.pages=e251121198293-e251121198293&rft.issn=1573-403X&rft.eissn=1875-6557&rft_id=info:doi/10.2174/1573403X17666211125090929&rft_dat=%3Cproquest_pubme%3E2643080737%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c451t-c5742acf9fca56814575ea776a04af03ecdb07a54515c3d00f2c23513a4ce47d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2643080737&rft_id=info:pmid/34823461&rfr_iscdi=true